Borkenstein M, Zobel V
Wien Klin Wochenschr. 1985 Apr 26;97(9):414-6.
53 prepubertal boys with untreated cryptorchidism were investigated in this study. 38 boys had unilateral, and 15 boys had bilateral cryptorchidism. 200 micrograms synthetic LHRH in a 0.2% aqueous solution (Cryptocur) were sprayed 3 times daily into each nostril (total dosage: 1.2 mg/d). The duration of therapy was 4 weeks. The boys were examined by palpation before, and then 2, 4 weeks and 6 months after commencement of treatment. Descent was achieved in 67.6% of testes; in the boys with unilateral cryptorchidism descent was achieved in 57.9% and in the boys with bilateral cryptorchidism in 80.0%. Follow-up control 6 months later showed relapse in 14 cases (30.4%). Treatment of cryptorchidism by intranasal application of LHRH, 3 times 400 micrograms/d is very effective. Administration is simple, painless and well tolerated. Follow-up is recommended, however, in view of the relatively high relapse rate.
本研究对53名青春期前未经治疗的隐睾症男孩进行了调查。38名男孩为单侧隐睾,15名男孩为双侧隐睾。将200微克合成促黄体生成素释放激素(LHRH)溶于0.2%的水溶液(隐睾停)中,每天向每个鼻孔喷3次(总剂量:1.2毫克/天)。治疗持续时间为4周。在治疗开始前以及治疗开始后2周、4周和6个月时,通过触诊对男孩进行检查。67.6%的睾丸下降;单侧隐睾症男孩中57.9%的睾丸下降,双侧隐睾症男孩中80.0%的睾丸下降。6个月后的随访对照显示,14例(30.4%)复发。经鼻应用LHRH,每天3次,每次400微克治疗隐睾症非常有效。给药简单、无痛且耐受性良好。然而,鉴于复发率相对较高,建议进行随访。